ArticleBMC cancer2017

Increased serum level of soluble interleukin-2 receptor is associated with a worse response of metastatic clear cell renal cell carcinoma to interferon alpha and sequential VEGF-targeting therapy.

Akinori Nukui et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.